25
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Ustekinumab in the Treatment of Generalized Pustular Psoriasis in a Pregnant Patient

, , , , & ORCID Icon
Pages 1107-1110 | Received 25 Nov 2023, Accepted 08 Apr 2024, Published online: 14 May 2024

References

  • Seishima M, Fujii K, Mizutani Y, et al. Generalized pustular psoriasis in pregnancy: current and future treatments. Am J Clin Dermatol. 2022;23(5):661–671. PMID: 35704168. doi:10.1007/s40257-022-00698-9
  • Chen TC, Iskandar IYK, Parisi R, et al. Global psoriasis atlas. fertility trends and adverse pregnancy outcomes in female patients with psoriasis in the UK. JAMA Dermatol. 2023;159(7):736–744. PMID: 37285130; PMCID: PMC10248813. doi:10.1001/jamadermatol.2023.1400
  • Megna M, Camela E, Ruggiero A, et al. Use of biological therapies for the management of pustular psoriasis: a new era?[J]. Clin Cosmet Invest Dermatol. 2023;1677–1690.
  • Sánchez-García V, Hernández-Quiles R, de-Miguel-Balsa E, et al. Exposure to biologic therapy before and during pregnancy in patients with psoriasis: systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2023. PMID: 37262303. doi:10.1111/jdv.19238
  • Choon SE, Navarini AA, Pinter A. Clinical course and characteristics of generalized pustular psoriasis. Am J Clin Dermatol. 2022;23(Suppl 1):21–29. PMID: 35061227; PMCID: PMC8801409. doi:10.1007/s40257-021-00654-z
  • Kaushik SB, Lebwohl MG. Psoriasis: which therapy for which patient[J]. J Am Acad Dermatol. 2019;80(1):27–40. doi:10.1016/j.jaad.2018.06.057
  • Owczarek W, Walecka I, Lesiak A, et al. The use of biological drugs in psoriasis patients prior to pregnancy, during pregnancy and lactation: a review of current clinical guidelines. Postepy Dermatol Alergol. 2020;37(6):821–830. PMID: 33603597; PMCID: PMC7874874. doi:10.5114/ada.2020.102089
  • Kurizky PS, Ferreira Cde C, Nogueira LS, et al. Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding. An Bras Dermatol. 2015;90(3):367–375. doi:10.1590/abd1806-4841.20153113
  • Förger F, Zbinden A, Villiger PM. Certolizumab treatmentduring late pregnancy in patients with rheumatic diseases: low drug levels in cord blood but possible risk for maternal infections. A case series of 13 patients. Joint Bone Spine. 2016;83(3):341–343. doi:10.1016/j.jbspin.2015.07.004
  • Yiu ZZ, Warren RB. Ustekinumab for the treatment of psoriasis: an evidence update. Semin Cutan Med Surg. 2018;37(3):143–147. PMID: 30215630. doi:10.12788/j.sder.2018.040
  • Galluzzo M, D’Adamio S, Bianchi L, et al. Psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab. J DermatolTreat. 2019;30(1):40–44.
  • Alsenaid A, Prinz JC. Inadvertent pregnancy during ustekinumab therapy in a patient with plaque psoriasis and impetigo herpetiformis[J]. J Eur Acad Dermatol Venereol. 2016;30(3):488–490. doi:10.1111/jdv.12872
  • Sheeran C, Nicolopoulos J. Pregnancy outcomes of two patients exposed to ustekinumab in the first trimester[J]. Australas J Dermatol. 2014;55(3):235–236. doi:10.1111/ajd.12214
  • Rocha K, Piccinin M C, Kalache LF, et al. Pregnancy during Ustekinumab Treatment for Severe Psoriasis[J]. Dermatology. 2015;231(2):103. doi:10.1159/000380880
  • Mugheddu C, Atzori L, Lappi A, et al. Biologics exposure during pregnancy and breastfeeding in a psoriasis patient. Dermatol Ther. 2019;32(3):e12895. PMID: 30958637. doi:10.1111/dth.12895
  • Mathieu RJ, Cobb CBC, Telang GH. New-onset pustular psoriasis in the setting of severe acute respiratory syndrome coronavirus 2 infection causing coronavirus disease 2019. JAAD Case Rep. 2020;6(12):1360–1362. PMID: 33102669; PMCID: PMC7566789. doi:10.1016/j.jdcr.2020.10.013
  • Shakoei S, Ghanadan A, Hamzelou S. Pustular psoriasis exacerbated by COVID-19 in a patient with the history of psoriasis. Dermatol Ther. 2020;33:e14462.
  • Martora F, Villani A, Battista T, et al. COVID-19 vaccination and inflammatory skin diseases. J Cosmet Dermatol. 2023;22(1):32–33. doi:10.1111/jocd.15414
  • Meng Y, Zeng F, Sun H, et al. Clinical characteristics and outcomes of patients with COVID-19 and psoriasis. J Med Virol. 2022;94(12):5850–5857. PMID: 36000295; PMCID: PMC9539270. doi:10.1002/jmv.28085